<!DOCTYPE html>
<html lang="en" dir="ltr" class="client-nojs">
<head>
<meta charset="UTF-8" />
<title>Adenosine monophosphate deaminase deficiency type 1 - Wikipedia, the free encyclopedia</title>
<meta name="generator" content="MediaWiki 1.26wmf13" />
<link rel="alternate" href="android-app://org.wikipedia/http/en.m.wikipedia.org/wiki/Adenosine_monophosphate_deaminase_deficiency_type_1" />
<link rel="alternate" type="application/x-wiki" title="Edit this page" href="/w/index.php?title=Adenosine_monophosphate_deaminase_deficiency_type_1&amp;action=edit" />
<link rel="edit" title="Edit this page" href="/w/index.php?title=Adenosine_monophosphate_deaminase_deficiency_type_1&amp;action=edit" />
<link rel="apple-touch-icon" href="/static/apple-touch/wikipedia.png" />
<link rel="shortcut icon" href="/static/favicon/wikipedia.ico" />
<link rel="search" type="application/opensearchdescription+xml" href="/w/opensearch_desc.php" title="Wikipedia (en)" />
<link rel="EditURI" type="application/rsd+xml" href="//en.wikipedia.org/w/api.php?action=rsd" />
<link rel="alternate" hreflang="x-default" href="/wiki/Adenosine_monophosphate_deaminase_deficiency_type_1" />
<link rel="copyright" href="//creativecommons.org/licenses/by-sa/3.0/" />
<link rel="alternate" type="application/atom+xml" title="Wikipedia Atom feed" href="/w/index.php?title=Special:RecentChanges&amp;feed=atom" />
<link rel="canonical" href="https://en.wikipedia.org/wiki/Adenosine_monophosphate_deaminase_deficiency_type_1" />
<link rel="stylesheet" href="//en.wikipedia.org/w/load.php?debug=false&amp;lang=en&amp;modules=ext.uls.nojs%7Cext.visualEditor.viewPageTarget.noscript%7Cext.wikihiero%7Cmediawiki.legacy.commonPrint%2Cshared%7Cmediawiki.sectionAnchor%7Cmediawiki.skinning.interface%7Cmediawiki.ui.button%7Cskins.vector.styles%7Cwikibase.client.init&amp;only=styles&amp;skin=vector&amp;*" />
<meta name="ResourceLoaderDynamicStyles" content="" />
<link rel="stylesheet" href="//en.wikipedia.org/w/load.php?debug=false&amp;lang=en&amp;modules=site&amp;only=styles&amp;skin=vector&amp;*" />
<style>a:lang(ar),a:lang(kk-arab),a:lang(mzn),a:lang(ps),a:lang(ur){text-decoration:none}
/* cache key: global:resourceloader:filter:minify-css:7:de1ab5287c9076b96eedd3f97a84a7b6 */</style>
<script src="//en.wikipedia.org/w/load.php?debug=false&amp;lang=en&amp;modules=startup&amp;only=scripts&amp;skin=vector&amp;*"></script>
<script>if(window.mw){
mw.config.set({"wgCanonicalNamespace":"","wgCanonicalSpecialPageName":false,"wgNamespaceNumber":0,"wgPageName":"Adenosine_monophosphate_deaminase_deficiency_type_1","wgTitle":"Adenosine monophosphate deaminase deficiency type 1","wgCurRevisionId":670573590,"wgRevisionId":670573590,"wgArticleId":159670,"wgIsArticle":true,"wgIsRedirect":false,"wgAction":"view","wgUserName":null,"wgUserGroups":["*"],"wgCategories":["Articles with contributors link","All articles with unsourced statements","Articles with unsourced statements from August 2011","Articles needing additional references from August 2011","All articles needing additional references","Articles with unsourced statements from November 2014","Articles that may contain original research from November 2014","All articles that may contain original research","Articles that use a Medicine navs subtemplate","Inborn errors of purine-pyrimidine metabolism","Rare diseases"],"wgBreakFrames":false,"wgPageContentLanguage":"en","wgPageContentModel":"wikitext","wgSeparatorTransformTable":["",""],"wgDigitTransformTable":["",""],"wgDefaultDateFormat":"dmy","wgMonthNames":["","January","February","March","April","May","June","July","August","September","October","November","December"],"wgMonthNamesShort":["","Jan","Feb","Mar","Apr","May","Jun","Jul","Aug","Sep","Oct","Nov","Dec"],"wgRelevantPageName":"Adenosine_monophosphate_deaminase_deficiency_type_1","wgRelevantArticleId":159670,"wgIsProbablyEditable":true,"wgRestrictionEdit":[],"wgRestrictionMove":[],"wgRedirectedFrom":"Myoadenylate_deaminase_deficiency","wgMediaViewerOnClick":true,"wgMediaViewerEnabledByDefault":true,"wikilove-recipient":"","wikilove-anon":0,"wgPoweredByHHVM":true,"wgWikiEditorEnabledModules":{"toolbar":true,"dialogs":true,"hidesig":true,"preview":false,"publish":false},"wgBetaFeaturesFeatures":[],"wgVisualEditor":{"pageLanguageCode":"en","pageLanguageDir":"ltr","usePageImages":true,"usePageDescriptions":true},"wgGatherShouldShowTutorial":true,"wgGatherPageImageThumbnail":"//upload.wikimedia.org/wikipedia/commons/thumb/f/fb/AMP_structure.svg/100px-AMP_structure.svg.png","wgULSAcceptLanguageList":[],"wgULSCurrentAutonym":"English","wgFlaggedRevsParams":{"tags":{"status":{"levels":1,"quality":2,"pristine":3}}},"wgStableRevisionId":null,"wgCategoryTreePageCategoryOptions":"{\"mode\":0,\"hideprefix\":20,\"showcount\":true,\"namespaces\":false}","wgNoticeProject":"wikipedia","wgInternalRedirectTargetUrl":"/wiki/Adenosine_monophosphate_deaminase_deficiency_type_1","wgWikibaseItemId":"Q1956662"});
}</script><script>if(window.mw){
mw.loader.implement("user.options",function($,jQuery){mw.user.options.set({"variant":"en"});});
/* cache key: global:resourceloader:filter:minify-js:7:b2706269305541eba923c165462b22c4 */
}</script>
<script>if(window.mw){
mw.loader.implement("user.tokens",function($,jQuery){mw.user.tokens.set({"editToken":"+\\","patrolToken":"+\\","watchToken":"+\\"});});
}</script>
<script>if(window.mw){
mw.loader.load(["mediawiki.action.view.redirect","mediawiki.page.startup","mediawiki.legacy.wikibits","mediawiki.legacy.ajax","ext.centralauth.centralautologin","mmv.head","ext.imageMetrics.head","ext.visualEditor.viewPageTarget.init","ext.uls.init","ext.uls.interface","ext.centralNotice.bannerController","skins.vector.js"]);
}</script>
<link rel="dns-prefetch" href="//meta.wikimedia.org" />
<!--[if lt IE 7]><style type="text/css">body{behavior:url("/w/static/1.26wmf13/skins/Vector/csshover.min.htc")}</style><![endif]-->
</head>
<body class="mediawiki ltr sitedir-ltr ns-0 ns-subject page-Adenosine_monophosphate_deaminase_deficiency_type_1 skin-vector action-view">
		<div id="mw-page-base" class="noprint"></div>
		<div id="mw-head-base" class="noprint"></div>
		<div id="content" class="mw-body" role="main">
			<a id="top"></a>

							<div id="siteNotice"><!-- CentralNotice --></div>
						<div class="mw-indicators">
</div>
			<h1 id="firstHeading" class="firstHeading" lang="en">Adenosine monophosphate deaminase deficiency type 1</h1>
									<div id="bodyContent" class="mw-body-content">
									<div id="siteSub">From Wikipedia, the free encyclopedia</div>
								<div id="contentSub"><span class="mw-redirectedfrom">  (Redirected from <a href="/w/index.php?title=Myoadenylate_deaminase_deficiency&amp;redirect=no" title="Myoadenylate deaminase deficiency">Myoadenylate deaminase deficiency</a>)</span></div>
												<div id="jump-to-nav" class="mw-jump">
					Jump to:					<a href="#mw-head">navigation</a>, 					<a href="#p-search">search</a>
				</div>
				<div id="mw-content-text" lang="en" dir="ltr" class="mw-content-ltr"><table class="infobox" style="width:22em">
<tr>
<th colspan="2" style="text-align:center;font-size:125%;font-weight:bold;background-color: lightgrey">Adenosine monophosphate deaminase deficiency type 1</th>
</tr>
<tr>
<td colspan="2" style="text-align:center"><a href="/wiki/File:AMP_structure.svg" class="image"><img alt="AMP structure.svg" src="//upload.wikimedia.org/wikipedia/commons/thumb/f/fb/AMP_structure.svg/230px-AMP_structure.svg.png" width="230" height="194" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/f/fb/AMP_structure.svg/345px-AMP_structure.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/f/fb/AMP_structure.svg/460px-AMP_structure.svg.png 2x" data-file-width="863" data-file-height="727" /></a>
<div><a href="/wiki/Adenosine_monophosphate" title="Adenosine monophosphate">Adenosine monophosphate</a></div>
</td>
</tr>
<tr>
<th colspan="2" style="text-align:center">Classification and external resources</th>
</tr>
<tr>
<th scope="row"><a href="/wiki/OMIM" title="OMIM" class="mw-redirect">OMIM</a></th>
<td><a rel="nofollow" class="external text" href="http://omim.org/entry/102770">102770</a></td>
</tr>
</table>
<p><b>Adenosine monophosphate deaminase deficiency type 1</b>, also called <b>myoadenylate deaminase deficiency</b> (MADD), is a <a href="/wiki/Recessive" title="Recessive" class="mw-redirect">recessive</a> <a href="/wiki/Genetics" title="Genetics">genetic</a> <a href="/wiki/Metabolic_disorder" title="Metabolic disorder" class="mw-redirect">metabolic disorder</a> that affects approximately 1–2% of populations of European descent.<sup id="cite_ref-ghr2008_1-0" class="reference"><a href="#cite_note-ghr2008-1"><span>[</span>1<span>]</span></a></sup> It appears to be considerably rarer in Asian populations.<sup id="cite_ref-ghr2008_1-1" class="reference"><a href="#cite_note-ghr2008-1"><span>[</span>1<span>]</span></a></sup> The genetic form is caused by a defect in the gene for <a href="/wiki/AMP_deaminase" title="AMP deaminase">AMP deaminase</a><sup id="cite_ref-ghr2008_1-2" class="reference"><a href="#cite_note-ghr2008-1"><span>[</span>1<span>]</span></a></sup> though there is also an acquired form of AMP deficiency.</p>
<p></p>
<div id="toc" class="toc">
<div id="toctitle">
<h2>Contents</h2>
</div>
<ul>
<li class="toclevel-1 tocsection-1"><a href="#Causes"><span class="tocnumber">1</span> <span class="toctext">Causes</span></a></li>
<li class="toclevel-1 tocsection-2"><a href="#Effects_of_failure_to_deaminate_the_AMP_molecules"><span class="tocnumber">2</span> <span class="toctext">Effects of failure to deaminate the AMP molecules</span></a></li>
<li class="toclevel-1 tocsection-3"><a href="#Symptoms"><span class="tocnumber">3</span> <span class="toctext">Symptoms</span></a></li>
<li class="toclevel-1 tocsection-4"><a href="#Treatment"><span class="tocnumber">4</span> <span class="toctext">Treatment</span></a></li>
<li class="toclevel-1 tocsection-5"><a href="#Potential_complications"><span class="tocnumber">5</span> <span class="toctext">Potential complications</span></a></li>
<li class="toclevel-1 tocsection-6"><a href="#References"><span class="tocnumber">6</span> <span class="toctext">References</span></a></li>
<li class="toclevel-1 tocsection-7"><a href="#Further_reading"><span class="tocnumber">7</span> <span class="toctext">Further reading</span></a></li>
</ul>
</div>
<p></p>
<h2><span class="mw-headline" id="Causes">Causes</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Adenosine_monophosphate_deaminase_deficiency_type_1&amp;action=edit&amp;section=1" title="Edit section: Causes">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p><a href="/wiki/AMP_deaminase" title="AMP deaminase">AMP deaminase</a> is an <a href="/wiki/Enzyme" title="Enzyme">enzyme</a> that converts <a href="/wiki/Adenosine_monophosphate" title="Adenosine monophosphate">adenosine monophosphate</a> (AMP) to <a href="/wiki/Inosine_monophosphate" title="Inosine monophosphate" class="mw-redirect">inosine monophosphate</a> (IMP), freeing an <a href="/wiki/Ammonia" title="Ammonia">ammonia</a> molecule in the process. It is a part of the <a href="/w/index.php?title=Metabolic_process&amp;action=edit&amp;redlink=1" class="new" title="Metabolic process (page does not exist)">metabolic process</a> that converts <a href="/wiki/Sugar" title="Sugar">sugar</a>, <a href="/wiki/Fat" title="Fat">fat</a>, and <a href="/wiki/Protein" title="Protein">protein</a> into cellular energy. In order to use energy, a <a href="/wiki/Cell_(biology)" title="Cell (biology)">cell</a> converts one of the above fuels into <a href="/wiki/Adenosine_triphosphate" title="Adenosine triphosphate">adenosine triphosphate</a> (ATP) via the <a href="/wiki/Mitochondrion" title="Mitochondrion">mitochondria</a>. Cellular processes, especially <a href="/wiki/Muscle" title="Muscle">muscles</a>, then convert the ATP into <a href="/wiki/Adenosine_diphosphate" title="Adenosine diphosphate">adenosine diphosphate</a> (ADP), freeing the energy to do work.<sup class="noprint Inline-Template Template-Fact" style="white-space:nowrap;">[<i><a href="/wiki/Wikipedia:Citation_needed" title="Wikipedia:Citation needed"><span title="This claim needs references to reliable sources. (August 2011)">citation needed</span></a></i>]</sup></p>
<p>During heavy or prolonged mild to moderate activity, other enzymes convert two molecules of ADP into one ATP molecule and one AMP molecule, making more ATP available to supply energy. AMP is normally converted into IMP by myoadenylate deaminase—so myoadenylate deaminase deficiency reduces energy that would be available to the cell through the <a href="/wiki/Purine_nucleotide_cycle" title="Purine nucleotide cycle">purine nucleotide cycle</a>. Instead of being converted to IMP, the AMP builds up in the cells of affected individuals, spills into the blood, and is eventually metabolized in the liver. In persons with a defective enzyme, <a href="/wiki/5%27-nucleotidase" title="5'-nucleotidase">5'-nucleotidase</a> removes the ribose and phosphorus from AMP, increasing levels of cellular and circulating adenosine by 16–25×.<sup id="cite_ref-2" class="reference"><a href="#cite_note-2"><span>[</span>2<span>]</span></a></sup><sup id="cite_ref-3" class="reference"><a href="#cite_note-3"><span>[</span>3<span>]</span></a></sup></p>
<h2><span class="mw-headline" id="Effects_of_failure_to_deaminate_the_AMP_molecules">Effects of failure to deaminate the AMP molecules</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Adenosine_monophosphate_deaminase_deficiency_type_1&amp;action=edit&amp;section=2" title="Edit section: Effects of failure to deaminate the AMP molecules">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<table class="metadata plainlinks ambox ambox-content ambox-Unreferenced" role="presentation">
<tr>
<td class="mbox-image">
<div style="width:52px"><a href="/wiki/File:Question_book-new.svg" class="image"><img alt="" src="//upload.wikimedia.org/wikipedia/en/thumb/9/99/Question_book-new.svg/50px-Question_book-new.svg.png" width="50" height="39" srcset="//upload.wikimedia.org/wikipedia/en/thumb/9/99/Question_book-new.svg/75px-Question_book-new.svg.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/9/99/Question_book-new.svg/100px-Question_book-new.svg.png 2x" data-file-width="262" data-file-height="204" /></a></div>
</td>
<td class="mbox-text"><span class="mbox-text-span">This section <b>does not <a href="/wiki/Wikipedia:Citing_sources" title="Wikipedia:Citing sources">cite</a> any <a href="/wiki/Wikipedia:Verifiability" title="Wikipedia:Verifiability">references or sources</a></b>. <span class="hide-when-compact">Please help improve this section by <a href="/wiki/Help:Introduction_to_referencing/1" title="Help:Introduction to referencing/1">adding citations to reliable sources</a>. Unsourced material may be challenged and <a href="/wiki/Wikipedia:Verifiability#Burden_of_evidence" title="Wikipedia:Verifiability">removed</a>.</span> <small><i>(August 2011)</i></small></span></td>
</tr>
</table>
<p>This failure to <a href="/wiki/Deamination" title="Deamination">deaminate</a> the AMP molecules has three major effects. First, significant amounts of AMP are lost from the cell and the body. Second, ammonia is not freed when the cell does work. Third, the level of IMP in the cell is not maintained.</p>
<ul>
<li>The first effect—the loss of AMP—is mostly significant because AMP contains <a href="/wiki/Ribose" title="Ribose">ribose</a>, a sugar molecule that is also used to make <a href="/wiki/DNA" title="DNA">DNA</a>, <a href="/wiki/RNA" title="RNA">RNA</a>, and some <a href="/wiki/Enzyme" title="Enzyme">enzymes</a>. Though the body can manufacture some ribose and obtain more from RNA-rich sources such as beans and red meat, this loss of ribose due to MADD is sometimes sufficient to create a shortage in the body, resulting in symptoms of severe fatigue and muscle pain. This outcome is especially likely if the individual regularly exercises vigorously or works physically over a period of weeks or months.</li>
<li>The second effect, the absence of ammonia, is not well understood. It may result in a reduction of the amount of <a href="/wiki/Fumarate" title="Fumarate" class="mw-redirect">fumarate</a> available to the <a href="/wiki/Citric_acid_cycle" title="Citric acid cycle">citric acid cycle</a>, and it may result in lower levels of <a href="/wiki/Nitric_oxide" title="Nitric oxide">nitric oxide</a> (a <a href="/wiki/Vasodilator" title="Vasodilator" class="mw-redirect">vasodilator</a>) in the body, reducing blood flow and <a href="/wiki/Oxygen" title="Oxygen">oxygen</a> intake during vigorous exercise, though this may be offset by increased levels of adenosine, another vasodilator.<sup id="cite_ref-4" class="reference"><a href="#cite_note-4"><span>[</span>4<span>]</span></a></sup></li>
<li>The third effect, the reduction in IMP, is also not well understood. It may somehow result in a reduction in the amount of <a href="/wiki/Lactic_acid" title="Lactic acid">lactic acid</a> produced by the muscles, though serum lactate is typically slightly elevated with MADD.<sup class="noprint Inline-Template Template-Fact" style="white-space:nowrap;">[<i><a href="/wiki/Wikipedia:Citation_needed" title="Wikipedia:Citation needed"><span title="This claim needs references to reliable sources. (November 2014)">citation needed</span></a></i>]</sup></li>
</ul>
<p>The following is a very simplified model of what may be going on inside a muscle cell with AMPD deficiency. There are two major semi-stable states: one with intra-cellular glycogen available, and one with glycogen exhausted. Both states are modified by how much the citric acid cycle is down-regulated by default.</p>
<table class="metadata plainlinks ambox ambox-content ambox-Original_research" role="presentation">
<tr>
<td class="mbox-image">
<div style="width:52px"><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/b/b4/Ambox_important.svg/40px-Ambox_important.svg.png" width="40" height="40" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/b/b4/Ambox_important.svg/60px-Ambox_important.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/b/b4/Ambox_important.svg/80px-Ambox_important.svg.png 2x" data-file-width="40" data-file-height="40" /></div>
</td>
<td class="mbox-text"><span class="mbox-text-span">This section <b>possibly contains <a href="/wiki/Wikipedia:No_original_research" title="Wikipedia:No original research">original research</a></b>. <span class="hide-when-compact">Please <a class="external text" href="//en.wikipedia.org/w/index.php?title=Adenosine_monophosphate_deaminase_deficiency_type_1&amp;action=edit">improve it</a> by <a href="/wiki/Wikipedia:Verifiability" title="Wikipedia:Verifiability">verifying</a> the claims made and adding <a href="/wiki/Wikipedia:Citing_sources#Inline_citations" title="Wikipedia:Citing sources">inline citations</a>. Statements consisting only of original research should be removed.</span> <small><i>(November 2014)</i></small></span></td>
</tr>
</table>
<p>Start from the state where glycogen is available and the citric acid cycle is severely down-regulated. Once the cell has received a non-trivial load, and has expended the phosphocreatine reserve, a small quantity of ATP will become discharged down to AMP. AMP will instantly up-regulate myophosphorylase, which will start liberating glucose from glycogen and make it available to the glycolytic pathway, producing pyruvate and recharging AMP back to ATP. Due to the greater availability of pyruvate as a substrate, and pyruvate also contributing a citric cycle intermediate, α-ketoglutarate, while consuming glutamate, the citric acid cycle will also speed up. The combination of glycolysis and the citric acid cycle now balances ATP production with ATP demand and the pool of AMP does not grow further. Because all pyruvate is not burned down in the citric acid cycle, the excess is converted to lactate and passed into blood.</p>
<p>In muscle cells with normal AMPD activity, the purine nucleotide cycle would now start to gradually add fumarate to the pool of the citric acid cycle intermediates. This would decrease the excess rate of pyruvate production by increasing its consumption, increase the rate of AMP recharge to ATP by the citric acid cycle, and consequently reduce liberation of glucose from glycogen, until increased supply of blood-borne fuels allows to shut down glycogenolysis completely.</p>
<p>In muscle cells with AMPD deficiency, ATP production rate of the citric acid cycle will not be synchronized with ATP demand. It was demonstrated,<sup id="cite_ref-5" class="reference"><a href="#cite_note-5"><span>[</span>5<span>]</span></a></sup> that muscle cells, that lack AMPD, stock and consume significantly more glutamate, and produce more alanine in this state, compared to healthy controls, which indicates occurrence of a higher concentration of pyruvate in the cell during exercise. The pool of AMP also grows bigger than in the controls, which would cause higher rate of glucose liberation from glycogen.</p>
<p>This state can last for as long as glycogen is available, and can be prolonged by constantly eating carbohydrate-rich food. If the load on muscles is greater than the body's ability to recycle lactate back into glucose, lactate will start to build up in the blood. Once lactate reaches its renal re-absorption threshold (5–6&#160;mmol/l in general population), it gets lost to urine, wasting many calories (and producing bright matte yellow particles in urine and irritation from extra acidity). In order to excrete lactate, kidney must also excrete magnesium as an obligatory cation, which may lead to acute and chronic magnesium deficiency. Supplementary magnesium in the form of lactate or citrate may be rapidly lost in the same way. Because magnesium is essential to aerobic metabolism, over time, magnesium loss may lead to a vicious cycle, where the citric acid cycle is further down-regulated, lactate production is increased, and magnesium loss is increased again.</p>
<p>If the muscle load is small, lactate is mostly recycled back into glucose or burned by other cells in the body. However the newly generated glucose is made available to all cells in the body, not just to muscle cells. The ability of the body to assimilate lactate may also be diminished, if working muscle cells cannot take up glucose from blood, due to myophosphorylase maintaining a higher concentration of it inside loaded cells, and if liver has already filled its glycogen stores up to capacity. So, ultimately, in this state, working muscle cells are destined to lose all glycogen. AMP breakdown to adenosine in this state is minor, because the pool of AMP is kept small by the vigorous regulatory action of myophosphorylase. Maximum continuous exertion is limited by the onset of burning sensation from lactate accumulation in muscles.</p>
<p>Eventually, all glycogen is exhausted, and the muscle cell enters another semi-stable state. During this transition, up-regulation of the citric acid cycle due to abundance of pyruvate is reversed, and a substantial part of the ATP pool is necessarily discharged down to AMP,<sup id="cite_ref-6" class="reference"><a href="#cite_note-6"><span>[</span>6<span>]</span></a></sup> which allows the citric acid cycle to be sped up by some other mechanism (perhaps by the allosteric mechanism that reacts to the lower concentration of ATP, or by amplification of the residual AMPD activity by the bloated AMP pool), until ATP production is balanced with ATP consumption. AMP conversion to adenosine, excretion to the blood (as AMP and its various metabolites), further conversion to uric acid and excretion to urine becomes significant for some time, until all AMP is eliminated from the muscle cell. The muscle movements become noticeably less precise. Breathing slows down. It becomes hard to rapidly increase the load on a muscle, as in McArdle's disease, and such a rapid load increase will dump even more purines into blood and urine (looking like translucent or rust-colored sharp shiny crystals and being highly irritating). The same situation would occur if blood flow to muscle cells becomes insufficient. Depending on how deeply the purine nucleotide pool is allowed to discharge, the risk of rhabdomyolysis goes up. On the other hand, there will be no lasting muscle pain from lactate, and continuous aerobic activity is possible. Oxidation of odd-numbered saturated fatty acids may provide another mechanism, although very gradual, to up-regulate citric acid cycle during exercise.</p>
<p>Most of the AMP probably spills into blood unchanged, and is gradually returned to the muscle cell, if its concentration there falls due to gradual recharge to ATP. The blood thus plays a role of a big AMP buffer. The spillover also limits, how much the residual AMPD activity can be amplified in this state.</p>
<p>If a food containing even small but perceivable amount of sugar (simple sugars or disaccharides that can be tasted sweet, or starch that is at least minimally hydrolyzed by salivary amylase, or even some non-sugar sweeteners) is eaten in this state, there may be a period of time after it enters stomach and before bulk absorption occurs, when continuous exercise becomes very hard, and easily triggers rhabdomyolysis. It probably happens because the digestive system senses and signals forthcoming delivery of sugars, inhibiting fatty acid release and oxidation, and starving glycogen-less muscle cells of the sole available source of energy. Even simple continuous exercise, like walking or washing dishes by hand right after the meal, may trigger rhabdomyolysis in the exercising muscles. This rhabdomyolysis is probably not of exertional, but of hypoglycemic nature, as loaded glycogen-less muscles can rapidly remove glucose from blood, and the normal mechanism of glucose homeostasis lacks the required responsiveness or capacity to prevent hypoglycemia. The lysed myocytes probably do not yield much glucose. Unlike the case with exertional rhabdomyolisys, there is no early warning signal. In a state of rest, however, the liver will effortlessly cover the whole body energy needs until absorption of carbohydrates occurs.</p>
<p>When a carbohydrate-rich food has been eaten before AMP has been eliminated from muscle cells, when bulk absorption starts, plenty of glucose becomes available in the blood, is taken up by muscle cells, is added to the glycogen store, but then immediately becomes liberated by the still up-regulated myophosphorylase. The resulting excess of glucose is metabolized down to lactic acid (the body cannot increase aerobic metabolism in an instant), recharging all AMP to ATP. The lactate is dumped back into blood and urine. The higher the glycemic index of the food is, the greater proportion of carbohydrates (and calories) is wasted into urine. If the person is at rest at this moment, and pays attention, a sudden increase in the breathing frequency due to lactate dumping is readily observable. If the rise in the blood lactate is particularly sharp, and the person happened to be breathing slowly, a heart palpitation may sometimes be observable. The lactic acidosis with palpitation may also occur during sleep, if stomach emptying has been delayed e.g. due to digestion requirements of the food or its high volume, and the person went to sleep before absorption has started. In this case the person will be awaken in a state of distress, with rapid breathing. Delayed stomach emptying creates especially favorable conditions for the shock lactic acidosis, because the digestive system may meanwhile still inhibit fatty acid release and oxidation. It has been experimentally demonstrated<sup id="cite_ref-7" class="reference"><a href="#cite_note-7"><span>[</span>7<span>]</span></a></sup>, that delayed gastric emptying prolongs the duration of the GLP-1 signal.</p>
<p>Once all AMP has been recharged to ATP, and glycogen stores allowed to replenish, the cell transitions back to the unmodified original state.</p>
<p>If carbohydrate-rich food is not consumed in this state, AMP elimination from the cell eventually completes, glycogen stores can be replenished again, and the cell transitions back to the original state but with reduced ATP pool and an up-regulated citric acid cycle.</p>
<h2><span class="mw-headline" id="Symptoms">Symptoms</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Adenosine_monophosphate_deaminase_deficiency_type_1&amp;action=edit&amp;section=3" title="Edit section: Symptoms">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>The majority of people with the AMPD gene are <a href="/wiki/Asymptomatic" title="Asymptomatic">asymptomatic</a>, but others have symptoms including early fatigue, muscle pain and muscle cramping.<sup id="cite_ref-8" class="reference"><a href="#cite_note-8"><span>[</span>8<span>]</span></a></sup></p>
<dl>
<dt>Fatigue</dt>
</dl>
<ul>
<li>MADD lowers aerobic power output, so increased anaerobic power is needed to perform the same amount of work.<sup class="noprint Inline-Template Template-Fact" style="white-space:nowrap;">[<i><a href="/wiki/Wikipedia:Citation_needed" title="Wikipedia:Citation needed"><span title="This claim needs references to reliable sources. (August 2011)">citation needed</span></a></i>]</sup></li>
<li>Without myoadenlyate deaminase, heavy activity causes adenosine to be released into the cell or perfused into the surrounding tissues. Fatigue and sedation after heavy exertion can be caused by excess adenosine in the cells which signals muscle fiber to feel fatigued. In the brain, excess adenosine decreases alertness and causes sleepiness. In this way, adenosine may play a role in fatigue from MADD.<sup id="cite_ref-9" class="reference"><a href="#cite_note-9"><span>[</span>9<span>]</span></a></sup></li>
<li>Recovery from over-exertion can be hours, days or even months. In cases of <a href="/wiki/Rhabdomyolysis" title="Rhabdomyolysis">rhabdomyolysis</a>, which is the rapid breakdown of muscle fibers, time to recovery is dependent on duration and intensity of original activity plus any excess activity during the recovery period.<sup class="noprint Inline-Template Template-Fact" style="white-space:nowrap;">[<i><a href="/wiki/Wikipedia:Citation_needed" title="Wikipedia:Citation needed"><span title="This claim needs references to reliable sources. (August 2011)">citation needed</span></a></i>]</sup></li>
</ul>
<dl>
<dt>Muscle pain</dt>
</dl>
<ul>
<li>Muscle pain from MADD is not well understood, but is partially due to high levels of lactate. Increased levels of free adenosine temporarily decrease pain, allowing over-exertion without awareness.<sup id="cite_ref-10" class="reference"><a href="#cite_note-10"><span>[</span>10<span>]</span></a></sup> The over exertion can cause mild to severe cases of rhabdomyolysis, which is painful.<sup id="cite_ref-mdafacts_11-0" class="reference"><a href="#cite_note-mdafacts-11"><span>[</span>11<span>]</span></a></sup></li>
<li>Adenosine mediates pain through <a href="/wiki/Adenosine_receptors" title="Adenosine receptors" class="mw-redirect">adenosine receptors</a>. MADD causes an increase of free adenosine during heavy activity which may cause exercise-induced muscle pain. Over time, excess free adenosine down-regulates primary A1 adenosine receptors, leading to increased muscle pain. Secondary receptors (A3) increase peripheral inflammation, which also increases pain.<sup id="cite_ref-12" class="reference"><a href="#cite_note-12"><span>[</span>12<span>]</span></a></sup><sup id="cite_ref-13" class="reference"><a href="#cite_note-13"><span>[</span>13<span>]</span></a></sup></li>
</ul>
<dl>
<dt>Muscle cramping</dt>
</dl>
<ul>
<li>The cause of cramping is unknown, but may be related to elevated lactate, increased calcium signaling across the <a href="/wiki/Sarcoplasmic_reticulum" title="Sarcoplasmic reticulum" class="mw-redirect">sarcoplasmic reticulum</a> caused by membrane instability from reduced levels of ATP, or increased levels of free adenosine.<sup id="cite_ref-14" class="reference"><a href="#cite_note-14"><span>[</span>14<span>]</span></a></sup></li>
</ul>
<dl>
<dt>Muscle weakness</dt>
</dl>
<ul>
<li>Muscle weakness is not a major symptom, though the progressive effects of chronic muscle damage from rhabdomyolysis will eventually cause significant weakness. Similarly, the long-term metabolic effects may result in nerve damage.<sup id="cite_ref-mdafacts_11-1" class="reference"><a href="#cite_note-mdafacts-11"><span>[</span>11<span>]</span></a></sup></li>
</ul>
<h2><span class="mw-headline" id="Treatment">Treatment</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Adenosine_monophosphate_deaminase_deficiency_type_1&amp;action=edit&amp;section=4" title="Edit section: Treatment">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>It is important for MADD patients to maintain strength and fitness without exercising or working to exhaustion. Learning this balance may be more difficult than normally, as muscle pain and fatigue may be perceived differently from normal individuals.<sup id="cite_ref-15" class="reference"><a href="#cite_note-15"><span>[</span>15<span>]</span></a></sup></p>
<p>Symptomatic relief from the effects of MADD may sometimes be achieved by administering <a href="/wiki/Ribose" title="Ribose">ribose</a> orally at a dose of approximately 10&#160;grams per 100 pounds (0.2 g/kg) of body weight per day, and exercise modulation as appropriate. Taken hourly, ribose provides a direct but limited source of energy for the cells. Patients with myoadenylate deaminase deficiency do not retain ribose during heavy exercise, so supplementation may be required to rebuild levels of ATP.<sup id="cite_ref-16" class="reference"><a href="#cite_note-16"><span>[</span>16<span>]</span></a></sup><sup id="cite_ref-17" class="reference"><a href="#cite_note-17"><span>[</span>17<span>]</span></a></sup></p>
<p><a href="/wiki/Creatine_monohydrate" title="Creatine monohydrate" class="mw-redirect">Creatine monohydrate</a> is also helpful for AMPD patients, as it provides an alternative source of energy for anaerobic muscle tissue.<sup id="cite_ref-18" class="reference"><a href="#cite_note-18"><span>[</span>18<span>]</span></a></sup> There is also clinical association of various muscular dystrophies with <a href="/wiki/Restless_legs_syndrome" title="Restless legs syndrome">restless legs syndrome</a> (RLS), which needs further clinical study for confirmation.</p>
<h2><span class="mw-headline" id="Potential_complications">Potential complications</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Adenosine_monophosphate_deaminase_deficiency_type_1&amp;action=edit&amp;section=5" title="Edit section: Potential complications">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>There is an increased risk that <a href="/wiki/Statin" title="Statin">statin</a> (cholesterol-reducing drugs) will cause <a href="/wiki/Myopathy" title="Myopathy">myopathy</a> (muscle weakness) in individuals with MADD.<sup id="cite_ref-19" class="reference"><a href="#cite_note-19"><span>[</span>19<span>]</span></a></sup></p>
<p>Anesthesia has the potential to cause <a href="/wiki/Malignant_hyperthermia" title="Malignant hyperthermia">malignant hyperthermia</a>, an uncontrolled increase in body temperature, and permanent muscle damage in patients with MADD. Individuals with MADD are advised to notify their anesthesiologist about their condition prior to surgery.<sup id="cite_ref-mdafacts_11-2" class="reference"><a href="#cite_note-mdafacts-11"><span>[</span>11<span>]</span></a></sup></p>
<p>In most cases where myopathy is present with MADD, a second muscle disease is present and symptoms are worse than either disease in isolation.<sup id="cite_ref-20" class="reference"><a href="#cite_note-20"><span>[</span>20<span>]</span></a></sup><sup id="cite_ref-21" class="reference"><a href="#cite_note-21"><span>[</span>21<span>]</span></a></sup></p>
<h2><span class="mw-headline" id="References">References</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Adenosine_monophosphate_deaminase_deficiency_type_1&amp;action=edit&amp;section=6" title="Edit section: References">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<div class="reflist" style="list-style-type: decimal;">
<ol class="references">
<li id="cite_note-ghr2008-1"><span class="mw-cite-backlink">^ <a href="#cite_ref-ghr2008_1-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-ghr2008_1-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-ghr2008_1-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><span class="citation web"><a rel="nofollow" class="external text" href="http://ghr.nlm.nih.gov/condition/adenosine-monophosphate-deaminase-deficiency">"Adenosine monophosphate deaminase deficiency"</a>. <i>Genetics Home Reference</i>. <a href="/wiki/United_States_National_Library_of_Medicine" title="United States National Library of Medicine">United States National Library of Medicine</a>. July 2008.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAdenosine+monophosphate+deaminase+deficiency+type+1&amp;rft.atitle=Adenosine+monophosphate+deaminase+deficiency&amp;rft.date=July+2008&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fghr.nlm.nih.gov%2Fcondition%2Fadenosine-monophosphate-deaminase-deficiency&amp;rft.jtitle=Genetics+Home+Reference&amp;rft.pub=United+States+National+Library+of+Medicine&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-2"><span class="mw-cite-backlink"><b><a href="#cite_ref-2">^</a></b></span> <span class="reference-text"><span class="citation journal">Sabina, R L; Swain, J L; Olanow, C W; Bradley, W G; Fishbein, W N; Dimauro, S; Holmes, E W (1984). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC425074">"Myoadenylate deaminase deficiency. Functional and metabolic abnormalities associated with disruption of the purine nucleotide cycle"</a>. <i>Journal of Clinical Investigation</i> <b>73</b> (3): 720–30. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1172%2FJCI111265">10.1172/JCI111265</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC425074">425074</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/6707201">6707201</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAdenosine+monophosphate+deaminase+deficiency+type+1&amp;rft.atitle=Myoadenylate+deaminase+deficiency.+Functional+and+metabolic+abnormalities+associated+with+disruption+of+the+purine+nucleotide+cycle&amp;rft.au=Bradley%2C+W+G&amp;rft.au=Dimauro%2C+S&amp;rft.aufirst=R+L&amp;rft.au=Fishbein%2C+W+N&amp;rft.au=Holmes%2C+E+W&amp;rft.aulast=Sabina&amp;rft.au=Olanow%2C+C+W&amp;rft.au=Sabina%2C+R+L&amp;rft.au=Swain%2C+J+L&amp;rft.date=1984&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC425074&amp;rft_id=info%3Adoi%2F10.1172%2FJCI111265&amp;rft_id=info%3Apmc%2F425074&amp;rft_id=info%3Apmid%2F6707201&amp;rft.issue=3&amp;rft.jtitle=Journal+of+Clinical+Investigation&amp;rft.pages=720-30&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=73" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-3"><span class="mw-cite-backlink"><b><a href="#cite_ref-3">^</a></b></span> <span class="reference-text"><span class="citation web">Loh, Evan (2000). <a rel="nofollow" class="external text" href="http://www.j-circ.or.jp/english/sessions/reports/64th-ss/loh.htm">"AMPD1 Genotype Predicts Survival in Patients with Heart Failure"</a>. Japanese Circulation Society.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAdenosine+monophosphate+deaminase+deficiency+type+1&amp;rft.aufirst=Evan&amp;rft.aulast=Loh&amp;rft.au=Loh%2C+Evan&amp;rft.btitle=AMPD1+Genotype+Predicts+Survival+in+Patients+with+Heart+Failure&amp;rft.date=2000&amp;rft.genre=book&amp;rft_id=http%3A%2F%2Fwww.j-circ.or.jp%2Fenglish%2Fsessions%2Freports%2F64th-ss%2Floh.htm&amp;rft.pub=Japanese+Circulation+Society&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-4"><span class="mw-cite-backlink"><b><a href="#cite_ref-4">^</a></b></span> <span class="reference-text"><span class="citation journal">Costa F, Biaggioni I (May 1998). "Role of nitric oxide in adenosine-induced vasodilation in humans". <i>Hypertension</i> <b>31</b> (5): 1061–4. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1161%2F01.HYP.31.5.1061">10.1161/01.HYP.31.5.1061</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/9576114">9576114</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAdenosine+monophosphate+deaminase+deficiency+type+1&amp;rft.atitle=Role+of+nitric+oxide+in+adenosine-induced+vasodilation+in+humans&amp;rft.au=Costa+F%2C+Biaggioni+I&amp;rft.aulast=Costa+F%2C+Biaggioni+I&amp;rft.date=May+1998&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1161%2F01.HYP.31.5.1061&amp;rft_id=info%3Apmid%2F9576114&amp;rft.issue=5&amp;rft.jtitle=Hypertension&amp;rft.pages=1061-4&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=31" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-5"><span class="mw-cite-backlink"><b><a href="#cite_ref-5">^</a></b></span> <span class="reference-text"><span class="citation journal">Tarnopolsky, Mark A.; Parise, Gianni; Gibala, Martin J.; Graham, Terry E.; Rush, James W. E. (15 June 2001). "Myoadenylate deaminase deficiency does not affect muscle anaplerosis during exhaustive exercise in humans". <i>The Journal of Physiology</i> <b>533</b> (3): 881–889. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1111%2Fj.1469-7793.2001.t01-1-00881.x">10.1111/j.1469-7793.2001.t01-1-00881.x</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAdenosine+monophosphate+deaminase+deficiency+type+1&amp;rft.atitle=Myoadenylate+deaminase+deficiency+does+not+affect+muscle+anaplerosis+during+exhaustive+exercise+in+humans&amp;rft.aufirst=Mark+A.&amp;rft.au=Gibala%2C+Martin+J.&amp;rft.au=Graham%2C+Terry+E.&amp;rft.aulast=Tarnopolsky&amp;rft.au=Parise%2C+Gianni&amp;rft.au=Rush%2C+James+W.+E.&amp;rft.au=Tarnopolsky%2C+Mark+A.&amp;rft.date=15+June+2001&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1111%2Fj.1469-7793.2001.t01-1-00881.x&amp;rft.issue=3&amp;rft.jtitle=The+Journal+of+Physiology&amp;rft.pages=881-889&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=533" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-6"><span class="mw-cite-backlink"><b><a href="#cite_ref-6">^</a></b></span> <span class="reference-text"><span class="citation journal">Sabina, Richard L.; Swain, Judith L.; Patten, Bernard M.; Ashizawa, Tetsuo; O'Brien, William E.; Holmes, Edward W. (1 December 1980). "Disruption of the Purine Nucleotide Cycle". <i>Journal of Clinical Investigation</i> <b>66</b> (6): 1419–1423. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1172%2FJCI109995">10.1172/JCI109995</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAdenosine+monophosphate+deaminase+deficiency+type+1&amp;rft.atitle=Disruption+of+the+Purine+Nucleotide+Cycle&amp;rft.au=Ashizawa%2C+Tetsuo&amp;rft.aufirst=Richard+L.&amp;rft.au=Holmes%2C+Edward+W.&amp;rft.aulast=Sabina&amp;rft.au=O%27Brien%2C+William+E.&amp;rft.au=Patten%2C+Bernard+M.&amp;rft.au=Sabina%2C+Richard+L.&amp;rft.au=Swain%2C+Judith+L.&amp;rft.date=1+December+1980&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1172%2FJCI109995&amp;rft.issue=6&amp;rft.jtitle=Journal+of+Clinical+Investigation&amp;rft.pages=1419-1423&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=66" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-7"><span class="mw-cite-backlink"><b><a href="#cite_ref-7">^</a></b></span> <span class="reference-text"><span class="citation journal">Frost, GS; Brynes, AE; Dhillo, WS; Bloom, SR; McBurney, MI (February 2003). "The effects of fiber enrichment of pasta and fat content on gastric emptying, GLP-1, glucose, and insulin responses to a meal.". <i>European journal of clinical nutrition</i> <b>57</b> (2): 293–8. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/12571662">12571662</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAdenosine+monophosphate+deaminase+deficiency+type+1&amp;rft.atitle=The+effects+of+fiber+enrichment+of+pasta+and+fat+content+on+gastric+emptying%2C+GLP-1%2C+glucose%2C+and+insulin+responses+to+a+meal.&amp;rft.au=Bloom%2C+SR&amp;rft.au=Brynes%2C+AE&amp;rft.au=Dhillo%2C+WS&amp;rft.aufirst=GS&amp;rft.au=Frost%2C+GS&amp;rft.aulast=Frost&amp;rft.au=McBurney%2C+MI&amp;rft.date=February+2003&amp;rft.genre=article&amp;rft_id=info%3Apmid%2F12571662&amp;rft.issue=2&amp;rft.jtitle=European+journal+of+clinical+nutrition&amp;rft.pages=293-8&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=57" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-8"><span class="mw-cite-backlink"><b><a href="#cite_ref-8">^</a></b></span> <span class="reference-text"><span class="citation web"><a rel="nofollow" class="external text" href="http://www.mda.org/disease/mad.html">"Myoadenylate Deaminase Deficiency"</a>. <a href="/wiki/Muscular_Dystrophy_Association" title="Muscular Dystrophy Association">Muscular Dystrophy Association</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAdenosine+monophosphate+deaminase+deficiency+type+1&amp;rft.btitle=Myoadenylate+Deaminase+Deficiency&amp;rft.genre=book&amp;rft_id=http%3A%2F%2Fwww.mda.org%2Fdisease%2Fmad.html&amp;rft.pub=Muscular+Dystrophy+Association&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-9"><span class="mw-cite-backlink"><b><a href="#cite_ref-9">^</a></b></span> <span class="reference-text"><span class="citation journal">Morisaki, H; Morisaki, T (2008). "AMPD genes and urate metabolism". <i>Nihon rinsho. Japanese journal of clinical medicine</i> <b>66</b> (4): 771–7. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/18409530">18409530</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAdenosine+monophosphate+deaminase+deficiency+type+1&amp;rft.atitle=AMPD+genes+and+urate+metabolism&amp;rft.aufirst=H&amp;rft.aulast=Morisaki&amp;rft.au=Morisaki%2C+H&amp;rft.au=Morisaki%2C+T&amp;rft.date=2008&amp;rft.genre=article&amp;rft_id=info%3Apmid%2F18409530&amp;rft.issue=4&amp;rft.jtitle=Nihon+rinsho.+Japanese+journal+of+clinical+medicine&amp;rft.pages=771-7&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=66" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-10"><span class="mw-cite-backlink"><b><a href="#cite_ref-10">^</a></b></span> <span class="reference-text"><span class="citation journal">Belfrage, Måns; Sollevi, Alf; Segerdahl, Märta; Sjölund, Karl-Fredrik; Hansson, Per (1995). <a rel="nofollow" class="external text" href="http://www.anesthesia-analgesia.org/cgi/pmidlookup?view=long&amp;pmid=7573999">"Systemic Adenosine Infusion Alleviates Spontaneous and Stimulus Evoked Pain in Patients with Peripheral Neuropathic Pain"</a>. <i>Anesthesia &amp; Analgesia</i> <b>81</b> (4): 713–7. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1097%2F00000539-199510000-00010">10.1097/00000539-199510000-00010</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/7573999">7573999</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAdenosine+monophosphate+deaminase+deficiency+type+1&amp;rft.atitle=Systemic+Adenosine+Infusion+Alleviates+Spontaneous+and+Stimulus+Evoked+Pain+in+Patients+with+Peripheral+Neuropathic+Pain&amp;rft.au=Belfrage%2C+M%C3%A5ns&amp;rft.aufirst=M%C3%A5ns&amp;rft.au=Hansson%2C+Per&amp;rft.aulast=Belfrage&amp;rft.au=Segerdahl%2C+M%C3%A4rta&amp;rft.au=Sj%C3%B6lund%2C+Karl-Fredrik&amp;rft.au=Sollevi%2C+Alf&amp;rft.date=1995&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fwww.anesthesia-analgesia.org%2Fcgi%2Fpmidlookup%3Fview%3Dlong%26pmid%3D7573999&amp;rft_id=info%3Adoi%2F10.1097%2F00000539-199510000-00010&amp;rft_id=info%3Apmid%2F7573999&amp;rft.issue=4&amp;rft.jtitle=Anesthesia+%26+Analgesia&amp;rft.pages=713-7&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=81" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-mdafacts-11"><span class="mw-cite-backlink">^ <a href="#cite_ref-mdafacts_11-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-mdafacts_11-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-mdafacts_11-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><span class="citation web"><a rel="nofollow" class="external text" href="http://www.mdausa.org/publications/PDFs/FactsAboutMetabolicDisease.pdf">"Facts About Metabolic Diseases of Muscle"</a> <span style="font-size:85%;">(PDF)</span>. <a href="/wiki/Muscular_Dystrophy_Association" title="Muscular Dystrophy Association">Muscular Dystrophy Association</a>. December 2009.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAdenosine+monophosphate+deaminase+deficiency+type+1&amp;rft.btitle=Facts+About+Metabolic+Diseases+of+Muscle&amp;rft.date=December+2009&amp;rft.genre=book&amp;rft_id=http%3A%2F%2Fwww.mdausa.org%2Fpublications%2FPDFs%2FFactsAboutMetabolicDisease.pdf&amp;rft.pub=Muscular+Dystrophy+Association&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-12"><span class="mw-cite-backlink"><b><a href="#cite_ref-12">^</a></b></span> <span class="reference-text"><span class="citation journal">Li, Xinhui; Bantel, Carsten; Conklin, Dawn; Childers, Steven R.; Eisenach, James C. (2004). "Repeated Dosing with Oral Allosteric Modulator of Adenosine A1 Receptor Produces Tolerance in Rats with Neuropathic Pain". <i>Anesthesiology</i> <b>100</b> (4): 956–61. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1097%2F00000542-200404000-00028">10.1097/00000542-200404000-00028</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/15087633">15087633</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAdenosine+monophosphate+deaminase+deficiency+type+1&amp;rft.atitle=Repeated+Dosing+with+Oral+Allosteric+Modulator+of+Adenosine+A1+Receptor+Produces+Tolerance+in+Rats+with+Neuropathic+Pain&amp;rft.au=Bantel%2C+Carsten&amp;rft.au=Childers%2C+Steven+R.&amp;rft.au=Conklin%2C+Dawn&amp;rft.au=Eisenach%2C+James+C.&amp;rft.aufirst=Xinhui&amp;rft.aulast=Li&amp;rft.au=Li%2C+Xinhui&amp;rft.date=2004&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1097%2F00000542-200404000-00028&amp;rft_id=info%3Apmid%2F15087633&amp;rft.issue=4&amp;rft.jtitle=Anesthesiology&amp;rft.pages=956-61&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=100" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-13"><span class="mw-cite-backlink"><b><a href="#cite_ref-13">^</a></b></span> <span class="reference-text"><span class="citation journal">Fredholm, B. B.; Halldner, L.; Johansson, C.; Schulte, G.; Lövdahl, C.; Thorén, P.; Dunwiddie, T. V.; Masino, S. A.; Poelchen, W.; Diao, L.; Illes, P.; Zahniser, N. R.; Valen, G.; Tokuno, S.; Sommerschild, H.; Giménez-Llort, L.; Fernández-Teruel, A.; Escorihuela, R. M.; Wiesenfeld-Hallin, Z.; Xu, X. J.; Hårdemark, A.; Herlenius, E.; Pekny, M.; Gebré-Medhin, S.; Brown, R.; Ollerstam, A.; Persson, A. E. G.; Skøtt, O.; Johansson, B. R. (2003). "Consequences of eliminating adenosine A1 receptors in mice". <i>Drug Development Research</i> <b>58</b> (4): 350. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1002%2Fddr.10170">10.1002/ddr.10170</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAdenosine+monophosphate+deaminase+deficiency+type+1&amp;rft.atitle=Consequences+of+eliminating+adenosine+A1+receptors+in+mice&amp;rft.au=Brown%2C+R.&amp;rft.au=Diao%2C+L.&amp;rft.au=Dunwiddie%2C+T.+V.&amp;rft.au=Escorihuela%2C+R.+M.&amp;rft.au=Fern%C3%A1ndez-Teruel%2C+A.&amp;rft.aufirst=B.+B.&amp;rft.au=Fredholm%2C+B.+B.&amp;rft.au=Gebr%C3%A9-Medhin%2C+S.&amp;rft.au=Gim%C3%A9nez-Llort%2C+L.&amp;rft.au=Halldner%2C+L.&amp;rft.au=H%C3%A5rdemark%2C+A.&amp;rft.au=Herlenius%2C+E.&amp;rft.au=Illes%2C+P.&amp;rft.au=Johansson%2C+B.+R.&amp;rft.au=Johansson%2C+C.&amp;rft.aulast=Fredholm&amp;rft.au=L%C3%B6vdahl%2C+C.&amp;rft.au=Masino%2C+S.+A.&amp;rft.au=Ollerstam%2C+A.&amp;rft.au=Pekny%2C+M.&amp;rft.au=Persson%2C+A.+E.+G.&amp;rft.au=Poelchen%2C+W.&amp;rft.au=Schulte%2C+G.&amp;rft.au=Sk%C3%B8tt%2C+O.&amp;rft.au=Sommerschild%2C+H.&amp;rft.au=Thor%C3%A9n%2C+P.&amp;rft.au=Tokuno%2C+S.&amp;rft.au=Valen%2C+G.&amp;rft.au=Wiesenfeld-Hallin%2C+Z.&amp;rft.au=Xu%2C+X.+J.&amp;rft.au=Zahniser%2C+N.+R.&amp;rft.date=2003&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1002%2Fddr.10170&amp;rft.issue=4&amp;rft.jtitle=Drug+Development+Research&amp;rft.pages=350&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=58" class="Z3988"><span style="display:none;">&#160;</span></span> <span class="plainlinks noprint" style="font-size:smaller"><a class="external text" href="//en.wikipedia.org/w/index.php?title=Template:Cite_doi/10.1002.2Fddr.10170&amp;action=edit&amp;editintro=Template:Cite_doi/editintro2">edit</a></span></span></li>
<li id="cite_note-14"><span class="mw-cite-backlink"><b><a href="#cite_ref-14">^</a></b></span> <span class="reference-text"><span class="citation journal">Blazev R, Lamb GD (December 1999). "Adenosine inhibits depolarization-induced Ca(2+) release in mammalian skeletal muscle.". <i>Muscle Nerve</i> <b>22</b> (12): 1674–83. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1002%2F%28SICI%291097-4598%28199912%2922%3A12%253C1674%3A%3AAID-MUS9%253E3.0.CO%3B2-0">10.1002/(SICI)1097-4598(199912)22:12%3C1674::AID-MUS9%3E3.0.CO;2-0</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/10567080">10567080</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAdenosine+monophosphate+deaminase+deficiency+type+1&amp;rft.atitle=Adenosine+inhibits+depolarization-induced+Ca%282%2B%29+release+in+mammalian+skeletal+muscle.&amp;rft.au=Blazev+R%2C+Lamb+GD&amp;rft.aulast=Blazev+R%2C+Lamb+GD&amp;rft.date=December+1999&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1002%2F%28SICI%291097-4598%28199912%2922%3A12%253C1674%3A%3AAID-MUS9%253E3.0.CO%3B2-0&amp;rft_id=info%3Apmid%2F10567080&amp;rft.issue=12&amp;rft.jtitle=Muscle+Nerve&amp;rft.pages=1674-83&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=22" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-15"><span class="mw-cite-backlink"><b><a href="#cite_ref-15">^</a></b></span> <span class="reference-text"><span class="citation journal">Lang, Robert (1998). <a rel="nofollow" class="external text" href="http://web.squ.edu.om/med-Lib/MED_CD/E_CDs/health%20development/html/clients/WAWFSA/html/papers/pap001.htm">"What is this Adenosine stuff?"</a>. <i>Australasian Anaesthesia</i>. <a href="/wiki/International_Standard_Serial_Number" title="International Standard Serial Number">ISSN</a>&#160;<a rel="nofollow" class="external text" href="//www.worldcat.org/issn/1032-2515">1032-2515</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAdenosine+monophosphate+deaminase+deficiency+type+1&amp;rft.atitle=What+is+this+Adenosine+stuff%3F&amp;rft.aufirst=Robert&amp;rft.au=Lang%2C+Robert&amp;rft.aulast=Lang&amp;rft.date=1998&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fweb.squ.edu.om%2Fmed-Lib%2FMED_CD%2FE_CDs%2Fhealth%2520development%2Fhtml%2Fclients%2FWAWFSA%2Fhtml%2Fpapers%2Fpap001.htm&amp;rft.issn=1032-2515&amp;rft.jtitle=Australasian+Anaesthesia&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-16"><span class="mw-cite-backlink"><b><a href="#cite_ref-16">^</a></b></span> <span class="reference-text"><span class="citation journal">Wagner, D.R.; Gresser, U.; Zöllner, N. (1991). "Effects of Oral Ribose on Muscle Metabolism during Bicycle Ergometer in AMPD-Deficient Patients". <i>Annals of Nutrition and Metabolism</i> <b>35</b> (5): 297–302. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1159%2F000177660">10.1159/000177660</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/1776826">1776826</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAdenosine+monophosphate+deaminase+deficiency+type+1&amp;rft.atitle=Effects+of+Oral+Ribose+on+Muscle+Metabolism+during+Bicycle+Ergometer+in+AMPD-Deficient+Patients&amp;rft.aufirst=D.R.&amp;rft.au=Gresser%2C+U.&amp;rft.aulast=Wagner&amp;rft.au=Wagner%2C+D.R.&amp;rft.au=Z%C3%B6llner%2C+N.&amp;rft.date=1991&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1159%2F000177660&amp;rft_id=info%3Apmid%2F1776826&amp;rft.issue=5&amp;rft.jtitle=Annals+of+Nutrition+and+Metabolism&amp;rft.pages=297-302&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=35" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-17"><span class="mw-cite-backlink"><b><a href="#cite_ref-17">^</a></b></span> <span class="reference-text"><span class="citation journal">Zöllner, N.; Reiter, S.; Gross, M.; Pongratz, D.; Reimers, C. D.; Gerbitz, K.; Paetzke, I.; Deufel, T.; Hübner, G. (1986). "Myoadenylate deaminase deficiency: Successful symptomatic therapy by high dose oral administration of ribose". <i>Klinische Wochenschrift</i> <b>64</b> (24): 1281–90. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1007%2FBF01785710">10.1007/BF01785710</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/3102830">3102830</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAdenosine+monophosphate+deaminase+deficiency+type+1&amp;rft.atitle=Myoadenylate+deaminase+deficiency%3A+Successful+symptomatic+therapy+by+high+dose+oral+administration+of+ribose&amp;rft.au=Deufel%2C+T.&amp;rft.aufirst=N.&amp;rft.au=Gerbitz%2C+K.&amp;rft.au=Gross%2C+M.&amp;rft.au=H%C3%BCbner%2C+G.&amp;rft.aulast=Z%C3%B6llner&amp;rft.au=Paetzke%2C+I.&amp;rft.au=Pongratz%2C+D.&amp;rft.au=Reimers%2C+C.+D.&amp;rft.au=Reiter%2C+S.&amp;rft.au=Z%C3%B6llner%2C+N.&amp;rft.date=1986&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1007%2FBF01785710&amp;rft_id=info%3Apmid%2F3102830&amp;rft.issue=24&amp;rft.jtitle=Klinische+Wochenschrift&amp;rft.pages=1281-90&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=64" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-18"><span class="mw-cite-backlink"><b><a href="#cite_ref-18">^</a></b></span> <span class="reference-text"><span class="citation book">Tarnopolsky, Mark A. (2007). <a rel="nofollow" class="external text" href="http://books.google.com/books?id=HjU1FYjjoRcC&amp;pg=PA182">"Clinical Use of Creatine in Neuromuscular and Neurometabolic Disorders"</a>. In Salomons, Gajja S.; Wyss, Markus. <i>Creatine and Creatine Kinase in Health and Disease</i>. Subcellular Biochemistry <b>46</b>. pp.&#160;183–204. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1007%2F978-1-4020-6486-9_10">10.1007/978-1-4020-6486-9_10</a>. <a href="/wiki/International_Standard_Book_Number" title="International Standard Book Number">ISBN</a>&#160;<a href="/wiki/Special:BookSources/978-1-4020-6485-2" title="Special:BookSources/978-1-4020-6485-2">978-1-4020-6485-2</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/18652078">18652078</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAdenosine+monophosphate+deaminase+deficiency+type+1&amp;rft.atitle=Clinical+Use+of+Creatine+in+Neuromuscular+and+Neurometabolic+Disorders&amp;rft.aufirst=Mark+A.&amp;rft.aulast=Tarnopolsky&amp;rft.au=Tarnopolsky%2C+Mark+A.&amp;rft.btitle=Creatine+and+Creatine+Kinase+in+Health+and+Disease&amp;rft.date=2007&amp;rft.genre=bookitem&amp;rft_id=http%3A%2F%2Fbooks.google.com%2Fbooks%3Fid%3DHjU1FYjjoRcC%26pg%3DPA182&amp;rft_id=info%3Adoi%2F10.1007%2F978-1-4020-6486-9_10&amp;rft_id=info%3Apmid%2F18652078&amp;rft.isbn=978-1-4020-6485-2&amp;rft.pages=183-204&amp;rft.series=Subcellular+Biochemistry&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.volume=46" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-19"><span class="mw-cite-backlink"><b><a href="#cite_ref-19">^</a></b></span> <span class="reference-text"><span class="citation journal">Vladutiu, Georgirene D.; Simmons, Zachary; Isackson, Paul J.; Tarnopolsky, Mark; Peltier, Wendy L.; Barboi, Alexandru C.; Sripathi, Naganand; Wortmann, Robert L.; Phillips, Paul S. (2006). "Genetic risk factors associated with lipid-lowering drug-induced myopathies". <i>Muscle &amp; Nerve</i> <b>34</b> (2): 153–62. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1002%2Fmus.20567">10.1002/mus.20567</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/16671104">16671104</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAdenosine+monophosphate+deaminase+deficiency+type+1&amp;rft.atitle=Genetic+risk+factors+associated+with+lipid-lowering+drug-induced+myopathies&amp;rft.au=Barboi%2C+Alexandru+C.&amp;rft.aufirst=Georgirene+D.&amp;rft.au=Isackson%2C+Paul+J.&amp;rft.aulast=Vladutiu&amp;rft.au=Peltier%2C+Wendy+L.&amp;rft.au=Phillips%2C+Paul+S.&amp;rft.au=Simmons%2C+Zachary&amp;rft.au=Sripathi%2C+Naganand&amp;rft.au=Tarnopolsky%2C+Mark&amp;rft.au=Vladutiu%2C+Georgirene+D.&amp;rft.au=Wortmann%2C+Robert+L.&amp;rft.date=2006&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1002%2Fmus.20567&amp;rft_id=info%3Apmid%2F16671104&amp;rft.issue=2&amp;rft.jtitle=Muscle+%26+Nerve&amp;rft.pages=153-62&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=34" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-20"><span class="mw-cite-backlink"><b><a href="#cite_ref-20">^</a></b></span> <span class="reference-text"><span class="citation journal">Vockley, Jerry; Rinaldo, Piero; Bennett, Michael J.; Matern, Dietrich; Vladutiu, Georgirene D. (2000). "Synergistic Heterozygosity: Disease Resulting from Multiple Partial Defects in One or More Metabolic Pathways". <i>Molecular Genetics and Metabolism</i> <b>71</b> (1–2): 10–8. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1006%2Fmgme.2000.3066">10.1006/mgme.2000.3066</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/11001791">11001791</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAdenosine+monophosphate+deaminase+deficiency+type+1&amp;rft.atitle=Synergistic+Heterozygosity%3A+Disease+Resulting+from+Multiple+Partial+Defects+in+One+or+More+Metabolic+Pathways&amp;rft.au=Bennett%2C+Michael+J.&amp;rft.aufirst=Jerry&amp;rft.aulast=Vockley&amp;rft.au=Matern%2C+Dietrich&amp;rft.au=Rinaldo%2C+Piero&amp;rft.au=Vladutiu%2C+Georgirene+D.&amp;rft.au=Vockley%2C+Jerry&amp;rft.date=2000&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1006%2Fmgme.2000.3066&amp;rft_id=info%3Apmid%2F11001791&amp;rft.issue=1%E2%80%932&amp;rft.jtitle=Molecular+Genetics+and+Metabolism&amp;rft.pages=10-8&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=71" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-21"><span class="mw-cite-backlink"><b><a href="#cite_ref-21">^</a></b></span> <span class="reference-text"><span class="citation journal">Sabina, Richard L. (2000). "MYOADENYLATE DEAMINASE DEFICIENCY: A Common Inherited Defect with Heterogeneous Clinical Presentation". <i>Neurologic Clinics</i> <b>18</b> (1): 185–94. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1016%2FS0733-8619%2805%2970184-5">10.1016/S0733-8619(05)70184-5</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/10658174">10658174</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAdenosine+monophosphate+deaminase+deficiency+type+1&amp;rft.atitle=MYOADENYLATE+DEAMINASE+DEFICIENCY%3A+A+Common+Inherited+Defect+with+Heterogeneous+Clinical+Presentation&amp;rft.aufirst=Richard+L.&amp;rft.aulast=Sabina&amp;rft.au=Sabina%2C+Richard+L.&amp;rft.date=2000&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2FS0733-8619%2805%2970184-5&amp;rft_id=info%3Apmid%2F10658174&amp;rft.issue=1&amp;rft.jtitle=Neurologic+Clinics&amp;rft.pages=185-94&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=18" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
</ol>
</div>
<h2><span class="mw-headline" id="Further_reading">Further reading</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Adenosine_monophosphate_deaminase_deficiency_type_1&amp;action=edit&amp;section=7" title="Edit section: Further reading">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<ul>
<li><span class="citation journal">Fischer, H.; Esbjornsson, M.; Sabina, R. L.; Stromberg, A.; Peyrard-Janvid, M.; Norman, B. (2007). "AMP deaminase deficiency is associated with lower sprint cycling performance in healthy subjects". <i>Journal of Applied Physiology</i> <b>103</b> (1): 315–22. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1152%2Fjapplphysiol.00185.2007">10.1152/japplphysiol.00185.2007</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/17463303">17463303</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAdenosine+monophosphate+deaminase+deficiency+type+1&amp;rft.atitle=AMP+deaminase+deficiency+is+associated+with+lower+sprint+cycling+performance+in+healthy+subjects&amp;rft.au=Esbjornsson%2C+M.&amp;rft.aufirst=H.&amp;rft.au=Fischer%2C+H.&amp;rft.aulast=Fischer&amp;rft.au=Norman%2C+B.&amp;rft.au=Peyrard-Janvid%2C+M.&amp;rft.au=Sabina%2C+R.+L.&amp;rft.au=Stromberg%2C+A.&amp;rft.date=2007&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1152%2Fjapplphysiol.00185.2007&amp;rft_id=info%3Apmid%2F17463303&amp;rft.issue=1&amp;rft.jtitle=Journal+of+Applied+Physiology&amp;rft.pages=315-22&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=103" class="Z3988"><span style="display:none;">&#160;</span></span></li>
<li><span class="citation journal">Skalova, K; Luptak, I; Turcani, M; Hulin, I (2002). <a rel="nofollow" class="external text" href="http://www.bmj.sk/2002/10306-01.pdf">"Adenosine and cardioprotection: what can we learn from nature's genetic polymorphism?"</a> <span style="font-size:85%;">(PDF)</span>. <i>Bratislavske lekarske listy</i> <b>103</b> (6): 187–93. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/12448564">12448564</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAdenosine+monophosphate+deaminase+deficiency+type+1&amp;rft.atitle=Adenosine+and+cardioprotection%3A+what+can+we+learn+from+nature%27s+genetic+polymorphism%3F&amp;rft.aufirst=K&amp;rft.au=Hulin%2C+I&amp;rft.aulast=Skalova&amp;rft.au=Luptak%2C+I&amp;rft.au=Skalova%2C+K&amp;rft.au=Turcani%2C+M&amp;rft.date=2002&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fwww.bmj.sk%2F2002%2F10306-01.pdf&amp;rft_id=info%3Apmid%2F12448564&amp;rft.issue=6&amp;rft.jtitle=Bratislavske+lekarske+listy&amp;rft.pages=187-93&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=103" class="Z3988"><span style="display:none;">&#160;</span></span></li>
</ul>
<table class="navbox" style="border-spacing:0">
<tr>
<td style="padding:2px">
<table class="nowraplinks collapsible autocollapse navbox-inner" style="border-spacing:0;background:transparent;color:inherit">
<tr>
<th scope="col" class="navbox-title" colspan="2">
<div class="plainlinks hlist navbar mini">
<ul>
<li class="nv-view"><a href="/wiki/Template:Inborn_errors_of_purine-pyrimidine_metabolism" title="Template:Inborn errors of purine-pyrimidine metabolism"><span title="View this template" style=";;background:none transparent;border:none;">v</span></a></li>
<li class="nv-talk"><a href="/wiki/Template_talk:Inborn_errors_of_purine-pyrimidine_metabolism" title="Template talk:Inborn errors of purine-pyrimidine metabolism"><span title="Discuss this template" style=";;background:none transparent;border:none;">t</span></a></li>
<li class="nv-edit"><a class="external text" href="//en.wikipedia.org/w/index.php?title=Template:Inborn_errors_of_purine-pyrimidine_metabolism&amp;action=edit"><span title="Edit this template" style=";;background:none transparent;border:none;">e</span></a></li>
</ul>
</div>
<div style="font-size:110%"><a href="/wiki/Inborn_error_of_metabolism" title="Inborn error of metabolism">Inborn error</a> of <a href="/wiki/Inborn_errors_of_purine-pyrimidine_metabolism" title="Inborn errors of purine-pyrimidine metabolism" class="mw-redirect">purine-pyrimidine metabolism</a> (<a href="/wiki/ICD-10_Chapter_IV:_Endocrine,_nutritional_and_metabolic_diseases#.28E79.E2.80.93E90.29_Other_metabolic_disorders" title="ICD-10 Chapter IV: Endocrine, nutritional and metabolic diseases">E79</a>, <a href="/wiki/List_of_ICD-9_codes_240%E2%80%93279:_endocrine,_nutritional_and_metabolic_diseases,_and_immunity_disorders#Other_metabolic_and_immunity_disorders_.28270.E2.80.93279.29" title="List of ICD-9 codes 240–279: endocrine, nutritional and metabolic diseases, and immunity disorders">277.2</a>)</div>
</th>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Purine_metabolism" title="Purine metabolism">Purine metabolism</a></th>
<td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em"></div>
<table class="nowraplinks navbox-subgroup" style="border-spacing:0">
<tr>
<th scope="row" class="navbox-group" style="padding-left:0;padding-right:0;">
<div style="padding:0em 0.75em;">Anabolism</div>
</th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Adenylosuccinate_lyase_deficiency" title="Adenylosuccinate lyase deficiency">Adenylosuccinate lyase deficiency</a></li>
<li><a href="/wiki/Adenosine_Monophosphate_Deaminase_Deficiency_type_1" title="Adenosine Monophosphate Deaminase Deficiency type 1" class="mw-redirect">Adenosine Monophosphate Deaminase Deficiency type 1</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group" style="padding-left:0;padding-right:0;">
<div style="padding:0em 0.75em;"><a href="/wiki/Nucleotide_salvage" title="Nucleotide salvage">Nucleotide salvage</a></div>
</th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Lesch%E2%80%93Nyhan_syndrome" title="Lesch–Nyhan syndrome">Lesch-Nyhan syndrome</a>/<a href="/wiki/Hyperuricemia" title="Hyperuricemia">Hyperuricemia</a></li>
<li><a href="/wiki/Adenine_phosphoribosyltransferase_deficiency" title="Adenine phosphoribosyltransferase deficiency">Adenine phosphoribosyltransferase deficiency</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group" style="padding-left:0;padding-right:0;">
<div style="padding:0em 0.75em;">Catabolism</div>
</th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Adenosine_deaminase_deficiency" title="Adenosine deaminase deficiency">Adenosine deaminase deficiency</a></li>
<li><a href="/wiki/Purine_nucleoside_phosphorylase_deficiency" title="Purine nucleoside phosphorylase deficiency">Purine nucleoside phosphorylase deficiency</a></li>
<li><a href="/wiki/Xanthinuria" title="Xanthinuria">Xanthinuria</a></li>
<li><a href="/wiki/Gout" title="Gout">Gout</a></li>
<li><a href="/wiki/Mitochondrial_neurogastrointestinal_encephalopathy_syndrome" title="Mitochondrial neurogastrointestinal encephalopathy syndrome">Mitochondrial neurogastrointestinal encephalopathy syndrome</a></li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Pyrimidine_metabolism" title="Pyrimidine metabolism">Pyrimidine metabolism</a></th>
<td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em"></div>
<table class="nowraplinks navbox-subgroup" style="border-spacing:0">
<tr>
<th scope="row" class="navbox-group" style="padding-left:0;padding-right:0;">
<div style="padding:0em 0.75em;">Anabolism</div>
</th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Orotic_aciduria" title="Orotic aciduria">Orotic aciduria</a></li>
<li><a href="/wiki/Miller_syndrome" title="Miller syndrome">Miller syndrome</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group" style="padding-left:0;padding-right:0;">
<div style="padding:0em 0.75em;">Catabolism</div>
</th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Dihydropyrimidine_dehydrogenase_deficiency" title="Dihydropyrimidine dehydrogenase deficiency">Dihydropyrimidine dehydrogenase deficiency</a></li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<td class="navbox-abovebelow" colspan="2" style="background: transparent; padding: 0px;">
<table class="nowraplinks navbox-subgroup" style="border-spacing:0">
<tr>
<th scope="col" class="navbox-title" colspan="2">
<div class="plainlinks hlist navbar mini">
<ul>
<li class="nv-view"><a href="/wiki/Template:Metabolic_navs" title="Template:Metabolic navs"><span title="View this template" style=";;background:none transparent;border:none;">v</span></a></li>
<li class="nv-talk"><a href="/wiki/Template_talk:Metabolic_navs" title="Template talk:Metabolic navs"><span title="Discuss this template" style=";;background:none transparent;border:none;">t</span></a></li>
<li class="nv-edit"><a class="external text" href="//en.wikipedia.org/w/index.php?title=Template:Metabolic_navs&amp;action=edit"><span title="Edit this template" style=";;background:none transparent;border:none;">e</span></a></li>
</ul>
</div>
<div style="font-size:110%">Index of <a href="/wiki/Inborn_error_of_metabolism" title="Inborn error of metabolism">inborn errors of metabolism</a></div>
</th>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">Description</th>
<td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Template:Metabolism" title="Template:Metabolism">Metabolism</a></li>
<li>Enzymes and pathways: <a href="/wiki/Template:Citric_acid_cycle" title="Template:Citric acid cycle">citric acid cycle</a>
<ul>
<li><a href="/wiki/Template:Citric_acid_cycle_enzymes_and_ETC" title="Template:Citric acid cycle enzymes and ETC">enzymes</a></li>
</ul>
</li>
<li><a href="/wiki/Template:Pentose_phosphate_pathway_enzymes" title="Template:Pentose phosphate pathway enzymes">pentose phosphate</a>
<ul>
<li><a href="/wiki/Template:Pentose_phosphate_pathway_intermediates" title="Template:Pentose phosphate pathway intermediates">intermediates</a></li>
</ul>
</li>
<li><a href="/wiki/Template:Glycoproteins" title="Template:Glycoproteins">glycoproteins</a>
<ul>
<li><a href="/wiki/Template:Glycoprotein_metabolism_enzymes" title="Template:Glycoprotein metabolism enzymes">enzymes</a></li>
</ul>
</li>
<li><a href="/wiki/Template:Glycosaminoglycans" title="Template:Glycosaminoglycans">glycosaminoglycans</a>
<ul>
<li><a href="/wiki/Template:Proteoglycan_metabolism_enzymes" title="Template:Proteoglycan metabolism enzymes">proteoglycan enzymes</a></li>
</ul>
</li>
<li><a href="/wiki/Template:Phospholipids" title="Template:Phospholipids">phospholipid</a>
<ul>
<li><a href="/wiki/Template:Phospholipid_metabolism" title="Template:Phospholipid metabolism">metabolism</a></li>
</ul>
</li>
<li><a href="/wiki/Template:Cholesterol_and_steroid_metabolism_enzymes" title="Template:Cholesterol and steroid metabolism enzymes">cholesterol and steroid</a>
<ul>
<li><a href="/wiki/Template:Cholesterol_and_steroid_intermediates" title="Template:Cholesterol and steroid intermediates">intermediates</a></li>
</ul>
</li>
<li><a href="/wiki/Template:Sphingolipids" title="Template:Sphingolipids">sphingolipids</a>
<ul>
<li><a href="/wiki/Template:Glycolipid/sphingolipid_metabolism_enzymes" title="Template:Glycolipid/sphingolipid metabolism enzymes" class="mw-redirect">enzymes</a></li>
</ul>
</li>
<li><a href="/wiki/Template:Eicosanoids" title="Template:Eicosanoids">eicosanoids</a>
<ul>
<li><a href="/wiki/Template:Eicosanoid_metabolism_enzymes" title="Template:Eicosanoid metabolism enzymes">enzymes</a></li>
</ul>
</li>
<li><a href="/wiki/Template:Amino_acid_metabolism_enzymes" title="Template:Amino acid metabolism enzymes">amino acid</a>
<ul>
<li><a href="/wiki/Template:Amino_acid_metabolism_intermediates" title="Template:Amino acid metabolism intermediates">intermediates</a></li>
</ul>
</li>
<li><a href="/wiki/Template:Urea_cycle" title="Template:Urea cycle">urea cycle</a>
<ul>
<li><a href="/wiki/Template:Urea_cycle_enzymes" title="Template:Urea cycle enzymes">enzymes</a></li>
</ul>
</li>
<li><a href="/wiki/Template:Nucleotide_metabolism_enzymes" title="Template:Nucleotide metabolism enzymes">nucleotide</a>
<ul>
<li><a href="/wiki/Template:Nucleotide_metabolism_intermediates" title="Template:Nucleotide metabolism intermediates">intermediates</a></li>
</ul>
</li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">Disorders</th>
<td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Template:Disorders_of_TCA_and_ETC" title="Template:Disorders of TCA and ETC">Citric acid cycle and electron transport chain</a></li>
<li><a href="/wiki/Template:Glycoprotein_disorders" title="Template:Glycoprotein disorders">Glycoprotein</a></li>
<li><a href="/wiki/Template:Proteoglycan_disorders" title="Template:Proteoglycan disorders">Proteoglycan</a></li>
<li><a href="/wiki/Template:Fatty-acid_metabolism_disorders" title="Template:Fatty-acid metabolism disorders">Fatty-acid</a></li>
<li><a href="/wiki/Template:Phospholipid_metabolism_disorders" title="Template:Phospholipid metabolism disorders">Phospholipid</a></li>
<li><a href="/wiki/Template:Defects_of_cholesterol_and_steroid_metabolism" title="Template:Defects of cholesterol and steroid metabolism">Cholesterol and steroid</a></li>
<li><a href="/wiki/Template:Eicosanoid_metabolism_disorders" title="Template:Eicosanoid metabolism disorders">Eicosanoid</a></li>
<li><a href="/wiki/Template:Amino_acid_metabolic_pathology" title="Template:Amino acid metabolic pathology">Amino acid</a></li>
<li><a href="/wiki/Template:Inborn_errors_of_purine-pyrimidine_metabolism" title="Template:Inborn errors of purine-pyrimidine metabolism">Purine-pyrimidine</a></li>
<li><a href="/wiki/Template:Heme_metabolism_disorders" title="Template:Heme metabolism disorders">Heme metabolism</a></li>
<li><a href="/wiki/Template:Eponymous_medical_signs_for_endocrinology,_nutrition,_and_metabolism" title="Template:Eponymous medical signs for endocrinology, nutrition, and metabolism">Symptoms and signs</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">Treatment</th>
<td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li>Drugs
<ul>
<li><a href="/wiki/Template:Other_alimentary_tract_and_metabolism_products" title="Template:Other alimentary tract and metabolism products">other</a></li>
</ul>
</li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
</table>
</td>
</tr>
</table>


<!-- 
NewPP limit report
Parsed by mw1124
CPU time usage: 0.503 seconds
Real time usage: 0.587 seconds
Preprocessor visited node count: 3259/1000000
Preprocessor generated node count: 0/1500000
Post‐expand include size: 123664/2097152 bytes
Template argument size: 2885/2097152 bytes
Highest expansion depth: 11/40
Expensive parser function count: 5/500
Lua time usage: 0.203/10.000 seconds
Lua memory usage: 4.1 MB/50 MB
-->

<!-- 
Transclusion expansion time report (%,ms,calls,template)
100.00%  475.421      1 - -total
 40.73%  193.620      1 - Template:Reflist
 19.37%   92.106     18 - Template:Cite_journal
 17.42%   82.838      4 - Template:Navbox
 17.32%   82.351      1 - Template:Infobox_disease
 14.96%   71.125      1 - Template:Infobox
 13.96%   66.359      4 - Template:Citation_needed
 12.72%   60.470      1 - Template:Inborn_errors_of_purine-pyrimidine_metabolism
 11.58%   55.030      4 - Template:Fix
 10.22%   48.590      8 - Template:Category_handler
-->

<!-- Saved in parser cache with key enwiki:pcache:idhash:159670-0!*!0!!en!4!* and timestamp 20150708205324 and revision id 670573590
 -->
<noscript><img src="//en.wikipedia.org/wiki/Special:CentralAutoLogin/start?type=1x1" alt="" title="" width="1" height="1" style="border: none; position: absolute;" /></noscript></div>					<div class="printfooter">
						Retrieved from "<a dir="ltr" href="https://en.wikipedia.org/w/index.php?title=Adenosine_monophosphate_deaminase_deficiency_type_1&amp;oldid=670573590">https://en.wikipedia.org/w/index.php?title=Adenosine_monophosphate_deaminase_deficiency_type_1&amp;oldid=670573590</a>"					</div>
				<div id='catlinks' class='catlinks'><div id="mw-normal-catlinks" class="mw-normal-catlinks"><a href="/wiki/Help:Category" title="Help:Category">Categories</a>: <ul><li><a href="/wiki/Category:Inborn_errors_of_purine-pyrimidine_metabolism" title="Category:Inborn errors of purine-pyrimidine metabolism">Inborn errors of purine-pyrimidine metabolism</a></li><li><a href="/wiki/Category:Rare_diseases" title="Category:Rare diseases">Rare diseases</a></li></ul></div><div id="mw-hidden-catlinks" class="mw-hidden-catlinks mw-hidden-cats-hidden">Hidden categories: <ul><li><a href="/wiki/Category:Articles_with_contributors_link" title="Category:Articles with contributors link">Articles with contributors link</a></li><li><a href="/wiki/Category:All_articles_with_unsourced_statements" title="Category:All articles with unsourced statements">All articles with unsourced statements</a></li><li><a href="/wiki/Category:Articles_with_unsourced_statements_from_August_2011" title="Category:Articles with unsourced statements from August 2011">Articles with unsourced statements from August 2011</a></li><li><a href="/wiki/Category:Articles_needing_additional_references_from_August_2011" title="Category:Articles needing additional references from August 2011">Articles needing additional references from August 2011</a></li><li><a href="/wiki/Category:All_articles_needing_additional_references" title="Category:All articles needing additional references">All articles needing additional references</a></li><li><a href="/wiki/Category:Articles_with_unsourced_statements_from_November_2014" title="Category:Articles with unsourced statements from November 2014">Articles with unsourced statements from November 2014</a></li><li><a href="/wiki/Category:Articles_that_may_contain_original_research_from_November_2014" title="Category:Articles that may contain original research from November 2014">Articles that may contain original research from November 2014</a></li><li><a href="/wiki/Category:All_articles_that_may_contain_original_research" title="Category:All articles that may contain original research">All articles that may contain original research</a></li><li><a href="/wiki/Category:Articles_that_use_a_Medicine_navs_subtemplate" title="Category:Articles that use a Medicine navs subtemplate">Articles that use a Medicine navs subtemplate</a></li></ul></div></div>				<div class="visualClear"></div>
							</div>
		</div>
		<div id="mw-navigation">
			<h2>Navigation menu</h2>

			<div id="mw-head">
									<div id="p-personal" role="navigation" class="" aria-labelledby="p-personal-label">
						<h3 id="p-personal-label">Personal tools</h3>
						<ul>
							<li id="pt-createaccount"><a href="/w/index.php?title=Special:UserLogin&amp;returnto=Adenosine+monophosphate+deaminase+deficiency+type+1&amp;type=signup" title="You are encouraged to create an account and log in; however, it is not mandatory">Create account</a></li><li id="pt-login"><a href="/w/index.php?title=Special:UserLogin&amp;returnto=Adenosine+monophosphate+deaminase+deficiency+type+1" title="You're encouraged to log in; however, it's not mandatory. [o]" accesskey="o">Log in</a></li>						</ul>
					</div>
									<div id="left-navigation">
										<div id="p-namespaces" role="navigation" class="vectorTabs" aria-labelledby="p-namespaces-label">
						<h3 id="p-namespaces-label">Namespaces</h3>
						<ul>
															<li  id="ca-nstab-main" class="selected"><span><a href="/wiki/Adenosine_monophosphate_deaminase_deficiency_type_1"  title="View the content page [c]" accesskey="c">Article</a></span></li>
															<li  id="ca-talk"><span><a href="/wiki/Talk:Adenosine_monophosphate_deaminase_deficiency_type_1"  title="Discussion about the content page [t]" accesskey="t" rel="discussion">Talk</a></span></li>
													</ul>
					</div>
										<div id="p-variants" role="navigation" class="vectorMenu emptyPortlet" aria-labelledby="p-variants-label">
												<h3 id="p-variants-label">
							<span>Variants</span><a href="#"></a>
						</h3>

						<div class="menu">
							<ul>
															</ul>
						</div>
					</div>
									</div>
				<div id="right-navigation">
										<div id="p-views" role="navigation" class="vectorTabs" aria-labelledby="p-views-label">
						<h3 id="p-views-label">Views</h3>
						<ul>
															<li id="ca-view" class="selected"><span><a href="/wiki/Adenosine_monophosphate_deaminase_deficiency_type_1" >Read</a></span></li>
															<li id="ca-edit"><span><a href="/w/index.php?title=Adenosine_monophosphate_deaminase_deficiency_type_1&amp;action=edit"  title="Edit this page [e]" accesskey="e">Edit</a></span></li>
															<li id="ca-history" class="collapsible"><span><a href="/w/index.php?title=Adenosine_monophosphate_deaminase_deficiency_type_1&amp;action=history"  title="Past versions of this page [h]" accesskey="h">View history</a></span></li>
													</ul>
					</div>
										<div id="p-cactions" role="navigation" class="vectorMenu emptyPortlet" aria-labelledby="p-cactions-label">
						<h3 id="p-cactions-label"><span>More</span><a href="#"></a></h3>

						<div class="menu">
							<ul>
															</ul>
						</div>
					</div>
										<div id="p-search" role="search">
						<h3>
							<label for="searchInput">Search</label>
						</h3>

						<form action="/w/index.php" id="searchform">
							<div id="simpleSearch">
							<input type="search" name="search" placeholder="Search" title="Search Wikipedia [f]" accesskey="f" id="searchInput" /><input type="hidden" value="Special:Search" name="title" /><input type="submit" name="fulltext" value="Search" title="Search Wikipedia for this text" id="mw-searchButton" class="searchButton mw-fallbackSearchButton" /><input type="submit" name="go" value="Go" title="Go to a page with this exact name if one exists" id="searchButton" class="searchButton" />							</div>
						</form>
					</div>
									</div>
			</div>
			<div id="mw-panel">
				<div id="p-logo" role="banner"><a class="mw-wiki-logo" href="/wiki/Main_Page"  title="Visit the main page"></a></div>
						<div class="portal" role="navigation" id='p-navigation' aria-labelledby='p-navigation-label'>
			<h3 id='p-navigation-label'>Navigation</h3>

			<div class="body">
									<ul>
						<li id="n-mainpage-description"><a href="/wiki/Main_Page" title="Visit the main page [z]" accesskey="z">Main page</a></li><li id="n-contents"><a href="/wiki/Portal:Contents" title="Guides to browsing Wikipedia">Contents</a></li><li id="n-featuredcontent"><a href="/wiki/Portal:Featured_content" title="Featured content – the best of Wikipedia">Featured content</a></li><li id="n-currentevents"><a href="/wiki/Portal:Current_events" title="Find background information on current events">Current events</a></li><li id="n-randompage"><a href="/wiki/Special:Random" title="Load a random article [x]" accesskey="x">Random article</a></li><li id="n-sitesupport"><a href="https://donate.wikimedia.org/wiki/Special:FundraiserRedirector?utm_source=donate&amp;utm_medium=sidebar&amp;utm_campaign=C13_en.wikipedia.org&amp;uselang=en" title="Support us">Donate to Wikipedia</a></li><li id="n-shoplink"><a href="//shop.wikimedia.org" title="Visit the Wikimedia Shop">Wikipedia store</a></li>					</ul>
							</div>
		</div>
			<div class="portal" role="navigation" id='p-interaction' aria-labelledby='p-interaction-label'>
			<h3 id='p-interaction-label'>Interaction</h3>

			<div class="body">
									<ul>
						<li id="n-help"><a href="/wiki/Help:Contents" title="Guidance on how to use and edit Wikipedia">Help</a></li><li id="n-aboutsite"><a href="/wiki/Wikipedia:About" title="Find out about Wikipedia">About Wikipedia</a></li><li id="n-portal"><a href="/wiki/Wikipedia:Community_portal" title="About the project, what you can do, where to find things">Community portal</a></li><li id="n-recentchanges"><a href="/wiki/Special:RecentChanges" title="A list of recent changes in the wiki [r]" accesskey="r">Recent changes</a></li><li id="n-contactpage"><a href="//en.wikipedia.org/wiki/Wikipedia:Contact_us">Contact page</a></li>					</ul>
							</div>
		</div>
			<div class="portal" role="navigation" id='p-tb' aria-labelledby='p-tb-label'>
			<h3 id='p-tb-label'>Tools</h3>

			<div class="body">
									<ul>
						<li id="t-whatlinkshere"><a href="/wiki/Special:WhatLinksHere/Adenosine_monophosphate_deaminase_deficiency_type_1" title="List of all English Wikipedia pages containing links to this page [j]" accesskey="j">What links here</a></li><li id="t-recentchangeslinked"><a href="/wiki/Special:RecentChangesLinked/Adenosine_monophosphate_deaminase_deficiency_type_1" title="Recent changes in pages linked from this page [k]" accesskey="k">Related changes</a></li><li id="t-upload"><a href="/wiki/Wikipedia:File_Upload_Wizard" title="Upload files [u]" accesskey="u">Upload file</a></li><li id="t-specialpages"><a href="/wiki/Special:SpecialPages" title="A list of all special pages [q]" accesskey="q">Special pages</a></li><li id="t-permalink"><a href="/w/index.php?title=Adenosine_monophosphate_deaminase_deficiency_type_1&amp;oldid=670573590" title="Permanent link to this revision of the page">Permanent link</a></li><li id="t-info"><a href="/w/index.php?title=Adenosine_monophosphate_deaminase_deficiency_type_1&amp;action=info" title="More information about this page">Page information</a></li><li id="t-wikibase"><a href="//www.wikidata.org/wiki/Q1956662" title="Link to connected data repository item [g]" accesskey="g">Wikidata item</a></li><li id="t-cite"><a href="/w/index.php?title=Special:CiteThisPage&amp;page=Adenosine_monophosphate_deaminase_deficiency_type_1&amp;id=670573590" title="Information on how to cite this page">Cite this page</a></li>					</ul>
							</div>
		</div>
			<div class="portal" role="navigation" id='p-coll-print_export' aria-labelledby='p-coll-print_export-label'>
			<h3 id='p-coll-print_export-label'>Print/export</h3>

			<div class="body">
									<ul>
						<li id="coll-create_a_book"><a href="/w/index.php?title=Special:Book&amp;bookcmd=book_creator&amp;referer=Adenosine+monophosphate+deaminase+deficiency+type+1">Create a book</a></li><li id="coll-download-as-rdf2latex"><a href="/w/index.php?title=Special:Book&amp;bookcmd=render_article&amp;arttitle=Adenosine+monophosphate+deaminase+deficiency+type+1&amp;oldid=670573590&amp;writer=rdf2latex">Download as PDF</a></li><li id="t-print"><a href="/w/index.php?title=Adenosine_monophosphate_deaminase_deficiency_type_1&amp;printable=yes" title="Printable version of this page [p]" accesskey="p">Printable version</a></li>					</ul>
							</div>
		</div>
			<div class="portal" role="navigation" id='p-lang' aria-labelledby='p-lang-label'>
			<h3 id='p-lang-label'>Languages</h3>

			<div class="body">
									<ul>
						<li class="interlanguage-link interwiki-de"><a href="//de.wikipedia.org/wiki/Myoadenylatdesaminase-Mangel" title="Myoadenylatdesaminase-Mangel – German" lang="de" hreflang="de">Deutsch</a></li><li class="uls-p-lang-dummy"><a href="#"></a></li>					</ul>
				<div class='after-portlet after-portlet-lang'><span class="wb-langlinks-edit wb-langlinks-link"><a href="//www.wikidata.org/wiki/Q1956662#sitelinks-wikipedia" title="Edit interlanguage links" class="wbc-editpage">Edit links</a></span></div>			</div>
		</div>
				</div>
		</div>
		<div id="footer" role="contentinfo">
							<ul id="footer-info">
											<li id="footer-info-lastmod"> This page was last modified on 8 July 2015, at 20:53.</li>
											<li id="footer-info-copyright">Text is available under the <a rel="license" href="//en.wikipedia.org/wiki/Wikipedia:Text_of_Creative_Commons_Attribution-ShareAlike_3.0_Unported_License">Creative Commons Attribution-ShareAlike License</a><a rel="license" href="//creativecommons.org/licenses/by-sa/3.0/" style="display:none;"></a>;
additional terms may apply.  By using this site, you agree to the <a href="//wikimediafoundation.org/wiki/Terms_of_Use">Terms of Use</a> and <a href="//wikimediafoundation.org/wiki/Privacy_policy">Privacy Policy</a>. Wikipedia® is a registered trademark of the <a href="//www.wikimediafoundation.org/">Wikimedia Foundation, Inc.</a>, a non-profit organization.</li>
									</ul>
							<ul id="footer-places">
											<li id="footer-places-privacy"><a href="//wikimediafoundation.org/wiki/Privacy_policy" title="wikimedia:Privacy policy">Privacy policy</a></li>
											<li id="footer-places-about"><a href="/wiki/Wikipedia:About" title="Wikipedia:About">About Wikipedia</a></li>
											<li id="footer-places-disclaimer"><a href="/wiki/Wikipedia:General_disclaimer" title="Wikipedia:General disclaimer">Disclaimers</a></li>
											<li id="footer-places-contact"><a href="//en.wikipedia.org/wiki/Wikipedia:Contact_us">Contact Wikipedia</a></li>
											<li id="footer-places-developers"><a href="https://www.mediawiki.org/wiki/Special:MyLanguage/How_to_contribute">Developers</a></li>
											<li id="footer-places-mobileview"><a href="//en.m.wikipedia.org/w/index.php?title=Adenosine_monophosphate_deaminase_deficiency_type_1&amp;mobileaction=toggle_view_mobile" class="noprint stopMobileRedirectToggle">Mobile view</a></li>
									</ul>
										<ul id="footer-icons" class="noprint">
											<li id="footer-copyrightico">
							<a href="//wikimediafoundation.org/"><img src="/static/images/wikimedia-button.png" srcset="/static/images/wikimedia-button-1.5x.png 1.5x, /static/images/wikimedia-button-2x.png 2x" width="88" height="31" alt="Wikimedia Foundation"/></a>						</li>
											<li id="footer-poweredbyico">
							<a href="//www.mediawiki.org/"><img src="//en.wikipedia.org/static/1.26wmf13/resources/assets/poweredby_mediawiki_88x31.png" alt="Powered by MediaWiki" srcset="//en.wikipedia.org/static/1.26wmf13/resources/assets/poweredby_mediawiki_132x47.png 1.5x, //en.wikipedia.org/static/1.26wmf13/resources/assets/poweredby_mediawiki_176x62.png 2x" width="88" height="31" /></a>						</li>
									</ul>
						<div style="clear:both"></div>
		</div>
		<script>if(window.jQuery)jQuery.ready();</script><script>if(window.mw){
mw.loader.state({"ext.globalCssJs.site":"ready","ext.globalCssJs.user":"ready","site":"loading","user":"ready","user.groups":"ready"});
}</script>
<link rel="stylesheet" href="//en.wikipedia.org/w/load.php?debug=false&amp;lang=en&amp;modules=ext.cite.styles%7Cext.gadget.DRN-wizard%2CReferenceTooltips%2CWatchlistGreenIndicators%2Ccharinsert%2Cfeatured-articles-links%2CrefToolbar%2Cswitcher%2Cteahouse%7Cext.wikimediaBadges&amp;only=styles&amp;skin=vector&amp;*" />
<script>if(window.mw){
mw.loader.load(["ext.cite.a11y","mediawiki.toc","mediawiki.action.view.postEdit","mediawiki.user","mediawiki.hidpi","mediawiki.page.ready","mediawiki.searchSuggest","ext.cirrusSearch.loggingSchema","mmv.bootstrap.autostart","ext.imageMetrics.loader","ext.eventLogging.subscriber","ext.wikimediaEvents","ext.wikimediaEvents.statsd","ext.navigationTiming","ext.gadget.teahouse","ext.gadget.ReferenceTooltips","ext.gadget.WatchlistGreenIndicators","ext.gadget.DRN-wizard","ext.gadget.charinsert","ext.gadget.refToolbar","ext.gadget.switcher","ext.gadget.featured-articles-links","ext.visualEditor.targetLoader","schema.UniversalLanguageSelector","ext.uls.eventlogger","ext.uls.interlanguage"],null,true);
}</script>
<script>if(window.mw){
document.write("\u003Cscript src=\"//en.wikipedia.org/w/load.php?debug=false\u0026amp;lang=en\u0026amp;modules=site\u0026amp;only=scripts\u0026amp;skin=vector\u0026amp;*\"\u003E\u003C/script\u003E");
}</script>
<script>if(window.mw){
mw.config.set({"wgBackendResponseTime":101,"wgHostname":"mw1059"});
}</script>
	</body>
</html>
